adenosine diphosphate has been researched along with thrombin receptor peptide (42-55) in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (57.14) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Cook, NS; Hagenbach, A; Metternich, R; Powling, M; Singh, J; Tapparelli, C; Zerwes, HG | 1 |
Dol, F; Herbert, JM; Savi, P | 1 |
Boudignon-Proudhon, C; Criss, AB; Dieter, MG; Parise, LV; Wencel-Drake, JD | 1 |
Barnard, MR; Benoit, SE; Furman, MI; Michelson, AD; Nurden, AT; Nurden, P | 1 |
Kawasaki, T; Kawashima, H; Maruyama, K; Sakai, Y; Shimizu, M; Takenaka, T; Taniuchi, Y | 1 |
Carroll, RC; Kouns, WC; Lanza, F; Steiner, B; Wang, XF | 1 |
Théroux, P; Xiao, Z | 1 |
Barnard, MR; Becker, RC; Benoit, SE; Borbone, ML; Furman, MI; Hechtman, HB; Michelson, AD; Valeri, CR | 1 |
Modi, NB; Novotny, W; Reimann, JD | 1 |
Gebauer, MU; Haeberli, A; Julmy, F; Meyer, BJ; Moshfegh, K; Redondo, M; Wuillemin, WA | 1 |
Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Rodis, FI; Tselepis, AD | 1 |
Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Tselepis, AD | 1 |
Fiore, M; Pillois, X; Pouget, T | 1 |
Do Sacramento, V; Eckly, A; Freund, M; Gachet, C; Hechler, B; Lanza, F; Mallo, L; Mangin, P; Strassel, C | 1 |
4 trial(s) available for adenosine diphosphate and thrombin receptor peptide (42-55)
Article | Year |
---|---|
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Enoxaparin; Female; Heparin; Humans; Male; Middle Aged; P-Selectin; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides | 1998 |
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.
Topics: Adenosine Diphosphate; Administration, Oral; Adult; Anticoagulants; Area Under Curve; Aspirin; Bleeding Time; Cross-Over Studies; Drug Interactions; Female; Heparin; Humans; Male; Middle Aged; Oximes; Partial Thromboplastin Time; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Prothrombin Time; Receptors, Thrombin | 2000 |
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
Topics: Adenosine Diphosphate; Adult; Aged; Antigens, CD; Aspirin; Blood; Clopidogrel; Collagen; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Humans; Middle Aged; Myocardial Infarction; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prospective Studies; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Tetraspanin 30; Ticlopidine | 2000 |
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; CD40 Ligand; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Stents; Ticlopidine; Treatment Outcome | 2004 |
10 other study(ies) available for adenosine diphosphate and thrombin receptor peptide (42-55)
Article | Year |
---|---|
Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Topics: Adenosine Diphosphate; Animals; Cricetinae; Fibrinogen; Flow Cytometry; Guinea Pigs; Humans; Macaca mulatta; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Rats; Species Specificity | 1993 |
ADP-dependence of platelet activation induced by a thrombin receptor agonist.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Amino Acid Sequence; Blood Platelets; Humans; In Vitro Techniques; Molecular Sequence Data; Peptide Fragments; Platelet Aggregation; Receptors, Cell Surface; Receptors, Thrombin | 1993 |
Internalization of bound fibrinogen modulates platelet aggregation.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Cell Compartmentation; Endocytosis; Fibrinogen; Flow Cytometry; Humans; Microscopy, Fluorescence; Molecular Sequence Data; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Zinc | 1996 |
The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system.
Topics: Actins; Adenosine Diphosphate; Adult; Amino Acid Sequence; Blood Platelets; Calcium; Cathepsin G; Cathepsins; Cell Compartmentation; Cell Degranulation; Cytoskeleton; Epinephrine; Humans; Immunohistochemistry; Leukocyte Elastase; Molecular Sequence Data; Pancreatic Elastase; Peptide Fragments; Platelet Glycoprotein GPIb-IX Complex; Serine Endopeptidases; Thrombin | 1996 |
Isolation and amino acid sequence of flavostatin, a novel disintegrin from the venom of Trimeresurus flavoviridis.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Collagen; Crotalid Venoms; Disintegrins; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Intercellular Signaling Peptides and Proteins; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Sequence Analysis; Sequence Homology, Amino Acid | 1997 |
Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Adenosine Diphosphate; Blood Platelets; Cytoplasmic Granules; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Lysophospholipids; Peptide Fragments; Phosphorylase a; Phosphorylation; Plasma; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Serotonin; Thrombasthenia; Thromboxane A2; Tyrosine; Vasoconstrictor Agents | 1997 |
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Cell Adhesion; Cell Adhesion Molecules; Cell Count; Cell Degranulation; Cell Movement; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Epinephrine; Female; Flow Cytometry; Humans; Leukocytes; Male; Middle Aged; Monocytes; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Receptors, Thrombin; Thrombosis | 1998 |
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Blood Platelets; CD40 Ligand; Cholesterol; Cholesterol, LDL; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Triglycerides | 2005 |
Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Apyrase; Blood Platelets; Humans; Peptide Fragments; Platelet Glycoprotein GPIb-IX Complex; Receptor, PAR-1; Receptors, Purinergic P2Y12; Thrombin | 2019 |
Functional properties of human platelets derived in vitro from CD34
Topics: Adenosine Diphosphate; Animals; Antigens, CD34; Blood Platelets; Cells, Cultured; Female; Glycoproteins; Hemostasis; In Vitro Techniques; Mice, Transgenic; Peptide Fragments; Platelet Aggregation; Platelet Transfusion; Stem Cells | 2020 |